- Home
- LRMR vs MRCC Comparison
LRMR vs MRCC Comparison
Compare LRMR & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- MRCC
- Stock Information
- Founded
- LRMR N/A
- MRCC 2011
- Country
- LRMR United States
- MRCC United States
- Employees
- LRMR N/A
- MRCC N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- MRCC Investment Managers
- Sector
- LRMR Health Care
- MRCC Finance
- Exchange
- LRMR Nasdaq
- MRCC Nasdaq
- Market Cap
- LRMR 183.8M
- MRCC 176.4M
- IPO Year
- LRMR N/A
- MRCC 2012
- Fundamental
- Price
- LRMR $2.04
- MRCC $7.84
- Analyst Decision
- LRMR Strong Buy
- MRCC Hold
- Analyst Count
- LRMR 10
- MRCC 1
- Target Price
- LRMR $19.60
- MRCC $8.00
- AVG Volume (30 Days)
- LRMR 911.3K
- MRCC 80.3K
- Earning Date
- LRMR 03-24-2025
- MRCC 05-07-2025
- Dividend Yield
- LRMR N/A
- MRCC 12.85%
- EPS Growth
- LRMR N/A
- MRCC 2515.72
- EPS
- LRMR N/A
- MRCC 0.45
- Revenue
- LRMR N/A
- MRCC $60,527,000.00
- Revenue This Year
- LRMR N/A
- MRCC N/A
- Revenue Next Year
- LRMR N/A
- MRCC N/A
- P/E Ratio
- LRMR N/A
- MRCC $17.37
- Revenue Growth
- LRMR N/A
- MRCC N/A
- 52 Week Low
- LRMR $2.07
- MRCC $7.01
- 52 Week High
- LRMR $11.20
- MRCC $8.85
- Technical
- Relative Strength Index (RSI)
- LRMR 31.08
- MRCC 40.54
- Support Level
- LRMR $2.19
- MRCC $7.60
- Resistance Level
- LRMR $2.44
- MRCC $7.92
- Average True Range (ATR)
- LRMR 0.18
- MRCC 0.16
- MACD
- LRMR -0.01
- MRCC 0.01
- Stochastic Oscillator
- LRMR 5.19
- MRCC 35.09
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.